CORCEPT THERAPEUTICS INC·4

Mar 26, 6:02 PM ET

MARDUEL ALIX 4

4 · CORCEPT THERAPEUTICS INC · Filed Mar 26, 2008

Insider Transaction Report

Form 4
Period: 2008-03-25
MARDUEL ALIX
Director
Transactions
  • Purchase

    Common Stock

    2008-03-25$2.77/sh+13,214$36,603166,491 total(indirect: By Fund)
  • Purchase

    Warrant

    2008-03-25$0.13/sh+522,960$65,370522,960 total(indirect: By Fund)
    Exercise: $2.77From: 2008-03-25Exp: 2015-03-25Common (522,960 underlying)
  • Purchase

    Warrant

    2008-03-25$0.13/sh+6,607$8266,607 total(indirect: By Fund)
    Exercise: $2.77From: 2008-03-25Exp: 2015-03-25Common (6,607 underlying)
  • Purchase

    Common Stock

    2008-03-25$2.77/sh+1,045,921$2,897,2015,043,299 total(indirect: By Fund)
Footnotes (3)
  • [F1]These securities are held by Alta BioPharma Partners II, L.P. ("ABPII").
  • [F2]The Reporting Person is a managing director of Alta BioPharma Management II, LLC ("ABMII"), which is the general partner of ABPII , and a manager of Alta Embarcadero Partners II, LLC ("AEBPII" and, along with ABPII, the "Funds"). The Reporting Person may be deemed to share voting and investment power over the shares held by the Funds. The Reporting Person disclaims beneficial ownership of all such shares held by the Funds, except to the extent of her pecuniary interests therein.
  • [F3]These securities are held by AEBPII.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION